Observing the temperature dependent transition of the GP2 peptide using terahertz spectroscopy

The GP2 peptide is derived from the Human Epidermal growth factor Receptor 2 (HER2/nue), a marker protein for breast cancer present in saliva. In this paper we study the temperature dependent behavior of hydrated GP2 at terahertz frequencies and find that the peptide undergoes a dynamic transition between 200 and 220 K. By fitting suitable molecular models to the frequency response we determine the molecular processes involved above and below the transition temperature (TD). In particular, we show that below TD the dynamic transition is dominated by a simple harmonic vibration with a slow and temperature dependent relaxation time constant and that above TD, the dynamic behavior is governed by two oscillators, one of which has a fast and temperature independent relaxation time constant and the other of which is a heavily damped oscillator with a slow and temperature dependent time constant. Furthermore a red shifting of the characteristic frequency of the damped oscillator was observed, confirming the presence of a non-harmonic vibration potential. Our measurements and modeling of GP2 highlight the unique capabilities of THz spectroscopy for protein characterization.Yiwen Sun, Zexuan Zhu, Siping Chen, Jega Balakrishnan, Derek Abbott, Anil T. Ahuja and Emma Pickwell-MacPherso

Bonelike apatite formation utilizing carbon nanotubes as template

10.1021/la9034722Langmuir2664069-4073LANG

Influence of cationic surfactants on the formation and surface oxidation states of gold nanoparticles produced via laser ablation

We report on the time evolution of gold nanoparticles produced by laser ablation in the presence of the cationic surfactants cetyltrimethylammonium bromide (CTAB) and cetyltrimethylammonium chloride (CTAC) in aqueous solution. The broader applicability of a laser-induced nanoparticle formation kinetic model previously developed by us for the case of anionic surfactants in aqueous solution [ J. Phys. Chem. C 2010, 114, 15931−15940] is shown to also apply in the presence of cationic surfactants. We explore the surface properties of the nanoparticles produced in the presence of the cationic surfactants via synchrotron X-ray photoelectron spectroscopy (XPS). The XPS data indicate that at CTA⁺ concentrations approximating the aqueous critical micelle concentration Au(III) is present on the nanoparticle surface. Such oxidation is not observed at (i) lower CTA+ concentrations, (ii) in the presence of an anionic surfactant, or (iii) in the case of pure water as a solvent.Yuen-Yan Fong, Jason R. Gascooke, Bradley R. Visser, Hugh H. Harris, Bruce C. C. Cowie, Lars Thomsen, Gregory F. Metha, and Mark A. Buntin

Influence of intracerebral hemorrhage location on incidence, characteristics, and outcome

Background and Purpose— The characteristics of intracerebral hemorrhage (ICH) may vary by ICH location because of differences in the distribution of underlying cerebral small vessel diseases. Therefore, we investigated the incidence, characteristics, and outcome of lobar and nonlobar ICH. Methods— In a population-based, prospective inception cohort study of ICH, we used multiple overlapping sources of case ascertainment and follow-up to identify and validate ICH diagnoses in 2010 to 2011 in an adult population of 695 335. Results— There were 128 participants with first-ever primary ICH. The overall incidence of lobar ICH was similar to nonlobar ICH (9.8 [95% confidence interval, 7.7–12.4] versus 8.6 [95% confidence interval, 6.7–11.1] per 100 000 adults/y). At baseline, adults with lobar ICH were more likely to have preceding dementia (21% versus 5%; P=0.01), lower Glasgow Coma Scale scores (median, 13 versus 14; P=0.03), larger ICHs (median, 38 versus 11 mL; P<0.001), subarachnoid extension (57% versus 5%; P<0.001), and subdural extension (15% versus 3%; P=0.02) than those with nonlobar ICH. One-year case fatality was lower after lobar ICH than after nonlobar ICH (adjusted odds ratio for death at 1 year: lobar versus nonlobar ICH 0.21; 95% confidence interval, 0.07–0.63; P=0.006, after adjustment for known predictors of outcome). There were 4 recurrent ICHs, which occurred exclusively in survivors of lobar ICH (annual risk of recurrent ICH after lobar ICH, 11.8%; 95% confidence interval, 4.6%–28.5% versus 0% after nonlobar ICH; log-rank P=0.04). Conclusions— The baseline characteristics and outcome of lobar ICH differ from other locations